Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Developing Countries Should Use Trade Rules to Circumvent Patent Laws on AIDS Drugs, WHO Official Says

September 23, 2005

Developing countries most affected by the HIV/AIDS pandemic should use domestic and international trade regulations to circumvent patent laws on antiretroviral drugs, Bernard Fabre-Teste, World Health Organization regional adviser on sexually transmitted diseases, said on Friday, the AP/Long Island Newsday reports. A lack of reduced-price antiretrovirals is a problem in many developing countries, Fabre-Teste said during a meeting of the World Health Organization Regional Office for the Western Pacific in Noumea, New Caledonia. He said that countries such as India, China and Vietnam should circumvent patent laws to produce generic drugs, adding that other countries should take steps to import generic versions of antiretrovirals. A 2003 World Trade Organization provision allows countries facing public health emergencies to issue compulsory licenses to manufacture and import generic versions of patented drugs; however, no country to date has used the provision because many governments fear trade sanctions from countries where the patents are held, according to Fabre-Teste. Officials should work together to ensure that public health needs are not disregarded for economic or trade interests, he said (Foley, AP/Long Island Newsday, 9/22).

Back to other news for September 23, 2005


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2005 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More on HIV Drug Patent Policies

Tools
 

Advertisement